Beyond counting cases: Public health impacts of national Paediatric Surveillance Units

Archives of Disease in Childhood

Volumn 92, Issue 6, 2007, Pages 527-533

  Grenier, D ^b   Elliott, Elizabeth J ^a   Zurynski, Y ^c   Rodrigues Pereira, R ^d   Preece, M ^e   Lynn, R ^e   Von Kries, R ^f   Zimmermann, H ^g   Dickson, N P ^h   Virella, D ⁱ  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

^d TNO   (Netherlands)

^e ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH   (United Kingdom)

^f Institute for Social Paediatrics and Adolescent Medicine   (Germany)

^g Swiss Paediatric Surveillance Unit   (Switzerland)

^h UNIVERSITY OF OTAGO   (New Zealand)

ⁱ Portuguese Paediatric Surveillance Unit   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHILDHOOD DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; GEOGRAPHIC DISTRIBUTION; HEALTH CARE; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MENTAL DISEASE; MOLECULAR EPIDEMIOLOGY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; REVIEW;

CHILD; CHILD HEALTH SERVICES; CONSUMER PRODUCT SAFETY; GENETIC DISEASES, INBORN; HEALTH POLICY; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; MENTAL DISORDERS; POPULATION SURVEILLANCE; PUBLIC HEALTH ADMINISTRATION;

EID: 34249914289     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.097451     Document Type: Review

References (59)

1. Gazarian M, Williams K, Chant K, et al. Evaluation of a national surveillance unit. Arch Dis Child 1999;23:128-31.
2. Elliott E, Nicoll A, Lynn R, et al. Rare disease surveillance: an international perspective. Paediatr Child Health 2001;6:251-60.
3. Kelly H, Brussen KA, Lawrence A, et al. Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996-2004. J Paediatr Child Health 2006;42:370-6.
4. Elliott EJ, McIntyre P, Ridley G, et al. A national study of infants hospitalised with pertussis in the acellular vaccine era. Paediatr Infect Dis J 2004;23:246-52.
5. Juretzko P, von-Kries R, Hermann M, et al. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis 2002;35:162-7.
6. Neppelenbroek SE, de Melker HE, Schellekens JFP, et al. Severity of pertussis. Paediatric surveillance and notification study in the Netherlands in 1997, RIVM-report no 128507006. Bilthoven: RIVM, 1999.
7. Kalies H, Verstraeten T, Grote V, et al. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. Paediatr Infect Dis J 2004;23:944-50.
8. Campbell C, Levin S, Humphreys P, et al. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr 2005;5:47-6.
9. Miller C, Andrews N, Rush M, et al. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 2004;89:1145-8.
10. Canadian Paediatric Society. CPSP highlights. Congenital rubella syndrome - Time to act on missed prevention opportunities. Paediatr Child Health 2003;8:107-8.
11. Forrest JM, Burgess M, Donovan T. A resurgence of congenital rubella in Australia? Commun Dis Intell 2003;27:533-6.
12. Davies HD. Necrotising fasciitis. In: Canadian Paediatric Surveillance Program 2003 results. Ottawa: Canadian Paediatric Society, 2004:33-7. Available from http://www.cps.ca/English/surveillance/cpsp/studies/ 2003Results.pdf (accessed 21 February 2007).
13. Ziebold C, von-Kries R, Lang R, et al. Severe complications of varicella in previously healthy children in Germany: a 1 year survey. Paediatrics 2001;108:E79.
14. Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infection in children and adolescents. Eur J Paediatr 2005;164:366-70.
15. Forrest JM, Mego S, Burgess MA. Congenital and neonatal varicella in Australia. J Paediatr Child Health 2000;36:108-13.
16. Von-Kries R, Seidler A, Schmidtt HJ, et al. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000;31:482-7.
17. Duong DM, Ades AE, Gibb DM, et al. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ 1999;319:1227-9.
18. Gibb DM, Duong T, Tookey PA, et al. National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003;327:1019-25.
19. McDonald AM, Li Y, Cruickshank MA, et al. Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust 2001;174:449-52.
20. Dickson N, Paul C, Wilkinson L, et al. Estimates of HIV prevalence among pregnant women in New Zealand. New Zealand Public Health Reports 2002;9:17-19.
21. Trijbels-Smeulders M, Gerards U, Pasker-de Jong PCM, et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. Paediatr Perinat Epidemiol 2002;16:334-41.
22. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-4.
23. Fluegge K, Siedler A, Heinrich B, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 2006;117:e1139-45.
24. Neto MT. Group B Streptococcus neonatal infection. In: Antsaklis A, ed. Proceedings of the XIX European Congress of Perinatal Medicine. Medimond: Atenas 2004:335-9.
25. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex infection in Canada: results of a 3-year national prospective study. Paediatrics 2006;117:1955-62.
26. Freedman E, Mindel A, Jones C. Epidemiological, clinical and laboratory diagnosis of neonatal herpes - an Australian perspective. Herpes 2004;11:38-40.
27. Wong T. Neonatal herpes simplex infection: In: Canadian Paediatric Surveillance Program 2003 results. Ottawa: Canadian Paediatric Society, 2004:34-7. Available from http://www.cps.ca/English/surveillance/cpsp/ studies/2003Results.pdf (accessed 21 February 2007).
28. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1997;10:432-42.
29. Lynn RM, O'Brien SJ, Taylor CM, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005;11:590-6.
30. Proulx F, Sockett P. Prospective surveillance of Canadian children with haemolytic uraemic syndrome. Paediatr Nephrol 2005;20:786- 90.
31. Elliott EJ, Robins-Browne RM, O'Loughlin EV, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological and epidemiological features. Arch Dis Child 2001;85:125-31.
32. Keene DL, Sutcliffe T, Harman P, et al. Surveillance for progressive intellectual and neurological deterioration in the Canadian paediatric population. Can J Neurol Sci 2004;31:220-4.
33. Devereux G, Stellitano L, Verity C, et al. Variations in neurodegenerative disease across the UK: findings from a national study of progressive and neurological deterioration (PIND). Arch Dis Child 2004;89:8-12.
34. Nunn K, Williams K, Ouvrier R. The Australian Childhood Dementia Study. Eur Child Adolesc Psychiatry 2002;11:63-70.
35. Morris A, Madden S, Katzman D, et al. Early onset eating disorders in young children: first report from the APSU and CPSP studies. Abstracts of the 4th INoPSU Conference, London, 2006.
36. Kozlowska K, Nunn K, Rose D, et al. Conversion disorder in Australian paediatric practice. J Am Acad Child Adolesc Psychiatry 2007;46(1):68-75.
37. Jureidini J, Shafer A, Donald T. Munchausen by proxy syndrome: not only pathological parenting but problematic doctoring? Med J Aust 2003;178:130-2.
38. Smith A, Egan J, Ridley G, et al. Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child 2003;88:263-4.
39. Nowaczyk MJM, Waye JS, Zeesman S, et al. Incidence of Smith-Lemli-Opitz syndrome in Canada: results of three-year population surveillance. J Paediatr 2004;145:503-5.
40. Colvin L, Fyfe S, Leonard S, et al. Describing the phenotype in Rett syndrome using a population database. Arch Dis Child 2003;88:38-43.
41. Prasad C, Marles S, Prasad AS, et al. Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype. Am J Med Genet 2002;108:64-8.
42. Moore H, Leonard H, de Klerk N, et al. Health service use in Rett syndrome. J Clin Neurol 2005;20:42-50.
43. Leonard H, Fyfe S, Dye D, et al. Using genetic epidemiology to study Rett syndrome: the design of a case-control study. Paediatr Perinat Epidemiol 2000;14:85-95.
44. Ellaway CJ, Peat J, Williams K, et al. Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev 2001;23(Suppl 1):S85-9.
45. Williams G, Wilson M, Rose D, et al. The epidemiology and clinical features of the CHARGE association in Australian children 2000-2002. Portuguese Paediatric Surveillance Unit Bulletin 2004;5(1):17.
46. Issekutz KA, Graham JM Jr, Prasad C, et al. An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet 2005;133:309-17.
47. Pollitt RJ, Leonard JV. Prospective surveillance study of medium-chain CoA dehydrogenase deficiency in the United Kingdom. Arch Dis Child 1998;79:116-19.
48. Hoffmann GF, von Kries R, Klose D, et al. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Pediatr 2004;163:76-80.
49. Cornelissen M, Von Kries R, Loughnan P, et al. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997;156:126-30.
50. McMillan DD, Grenier D, Medaglia A. Canadian Paediatric Surveillance Program confirms low incidence of hemorrhagic disease of the newborn in Canada. Paediatr Child Health 2004;9:235-8.
51. Schubiger G, Berger TM, Weber R, et al. Prevention of vitamin K deficiency bleeding with oral mixed micellar phylloquinone: results of a 6 year surveillance in Switzerland. Eur J Pediatr 2003;162:885- 8.
52. Newton L, Hall SM. Reye's syndrome in the British Isles: report for 1990/91 and the first decade of surveillance. Commun Dis Rep CDR Rev 1993;3:R11-6.
53. Macdonald S. Aspirin use to be banned in under 16 year olds. BMJ 2002;325:988.
54. Elliott EJ, Bower C. FAS in Australia: fact or fiction? J Paediatr Child Health 2004;40:8-10.
55. Elliott EJ, Payne J, Haan E, et al. Diagnosis of fetal alcohol syndrome and alcohol use in pregnancy: a survey of paediatricians' knowledge, attitudes and practice. J Paediatr Child Health 2006;42:698-703.
56. Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005;90:737-40.
57. Mucklow ES. Chemistry set poisoning. Int J Clin Pract 1997;51:321-3.
58. Grenier D, Doherty J, Macdonald D, et al. Canadian Paediatric Surveillance Program Evaluation: an excellent report card. Paediatr Child Health 2004;9:379-84.
59. Cyr C, Lemoine C, Santschi M. Lap-belt syndrome. In: Canadian Paediatric Surveillance Program 2005 results. Ottawa: Canadian Paediatric Society, 2006:38-9. Available from http://www.cps.ca/English/surveillance/cpsp/ studies/2005Results.pdf (accessed 21 February 2007).